Sponsor

Agencja Badań Medycznych

Poland ul. Chmielna 69, 00-801 Warsaw, Poland

About the sponsor

The sponsor funds research in acute coronary syndrome, myocardial infarction, heart failure, arrhythmogenic cardiomyopathy, and antiplatelet therapy, with additional focus on transcatheter edge-to-edge repair and left atrial appendage closure. Its portfolio also includes prevention and treatment of anthracycline-related cardiotoxicity and cancer therapeutics-related cardiac dysfunction.

Acute coronary syndrome and post-infarction care
Heart failure and cardiac dysfunction
Cardiotoxicity in cancer treatment
Antithrombotic and antiplatelet strategies

Research activity also covers iron deficiency in cardiac disease and fibrotic and remodeling pathways in structural heart conditions.

About Specializations

Agencja Badań Medycznych runs clinical trials in conditions such as Hypertension, Cardiac failure, Cardiomyopathy, Atrial fibrillation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

28 clinical trials

Nephrotic syndrome

Recruiting

Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

Registered drugNo placebo

Study on the Effectiveness of Ketoanalogues in Preventing Muscle Loss in Patients with Nephrotic Syndrome

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Keto-Leucine Calcium
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Post-acute COVID-19 syndrome

Recruiting

Title: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19

Registered drug

Title: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Tianeptine Sodium
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Myocardial infarction

Recruiting

Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

Registered drug

Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Crohn's disease

Recruiting

Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn's Disease

Registered drugNo placebo

Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn's Disease

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Infliximab
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Colitis ulcerative

Recruiting

Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

Registered drugNo placebo

Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Infliximab
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Giant cell arteritis

Recruiting

Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

Registered drugNo placebo

Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Etanercept
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Coronary artery disease+1

Recruiting

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Lichen sclerosus+1

Recruiting

Study on Clobetasol, Mometasone, and Tacrolimus for Treating Vulvar Lichen Sclerosus in Children

Registered drugNo placebo

Study on Clobetasol, Mometasone, and Tacrolimus for Treating Vulvar Lichen Sclerosus in Children

Registered drugNo placebo

Poland

Participants:0–17 years · 18–64 years
Substances:Mometasone Furoate
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Hypertension

Recruiting

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Registered drug